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Australia’s medical marijuana
subterfuge
Gary Christian

Research Director, Drug Free Australia, Central Coast, NSW

It is a little known fact that medical cannabis
has been legally available on prescription
from General Practitioners for more than 18
years in Australia. The curious media calls
to ‘legalise’ an already legal medication has
generated the illusion that medical cannabis
has always been as illegal as its recreational
use, and that State and Federal Governments
really do need to make the legality of medical
cannabis a reality. So why has the Australian
media almost uniformly been keeping the
Australian public in the dark about the already
legal status of medical cannabis, and why has
it campaigned so strongly and deceptively
about something we have long had, albeit rarely
used? This discussion informs educators and
potentially their students, particularly in areas
within current personal development and health
curricula.
Some background
Back in 1999, a NSW parliamentary briefing
paper (Griffith & Swain) noted that in 1997 general
practitioners were prescribing the pill Marinol for 100
patients in NSW under the Australian Therapeutic
Goods Administration (TGA) Special Access
Scheme. Marinol, otherwise called Dronabinol, is
a synthetic form of the psychoactive constituent
in cannabis, tetrahydrocannabinol, the chemical
properties of which were isolated and then
reproduced when Marinol first entered the market in
1985. The therapeutic effect of Marinol lasts twice
as long as smoked cannabis with the same ‘high’ but
also exhibits the same negative side-effects such as
dizziness, anxiety and confusion (Cooper, Comer, &
Haney, 2013).
In 2012, a cannabis whole-plant extract, Sativex,
was registered with the TGA for use by Multiple
Sclerosis patients in the form of an oral spray.
Sativex was stocked by Australian pharmacies for
a short time before being withdrawn due to lack
of interest by patients. Nevertheless the TGA has
confirmed in writing (Drug Free Australia, 2015)
that GPs are able, under their Special Access
Scheme, to prescribe Sativex, as with Marinol,

for patients with a variety of other conditions that
might be alleviated by cannabis. Internet-purchased
Sativex can be imported legally into Australia with
a permit so long as it has been prescribed. These
confirmations from the TGA have been described
and sent in multiple letters and opinion pieces by
Drug Free Australia, the country’s peak prevention
body, to each of the major press, radio and television
outlets throughout Australia to correct their false
understanding. None have ever responded or
changed their rhetoric.

“

Medical indications for cannabis
Many claims have been made by cannabis users
about the benefits of cannabis medicinally, but the
majority of these claims have evaporated under
the scrutiny of clinical trials. Because cannabis has
a well-documented withdrawal syndrome, many
of these claims only address the effectiveness of
cannabis in alleviating its own withdrawal symptoms
– pain, muscle spasm, agitation, fits, convulsions
and rheumatics are the most common (Reece, 2014).
This is important because many of the patients
who present public testimony before Parliamentary
inquiries are speaking from a background of prior
cannabis dependency and addiction.
Rigorous clinical trials have isolated a number
of conditions where actual benefit has been
demonstrated. In terms of chronic pain, where
cannabis has a mild analgesic effect comparable in
strength to codeine, it can become a useful adjunct
for those who don’t tolerate opiates well. Cannabis
can alleviate some symptoms of MS, reduce
nausea and vomiting, and reduce AIDS wasting by
increasing appetite in patients (Institute of Medicine,
1999). For each of these conditions there are more
effective medications available to doctors, and
so medical cannabinoids do not in any of these
conditions represent a first-line treatment, or second
or third for that matter, available to doctors (Reece,
2014). Consequently, it is revealing that the calls
for medical cannabis have not been coming from
doctors or their medical associations, but rather from
people with an entirely different agenda.
In 2014, significant publicity was given to the
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effect of cannabis on Dravet’s and Lennox-Gastaut’s
syndromes, which both cause severe epilepsylike seizures particularly in young children. Some
children have been helped by the use of cannabis
strains high in Cannabidiol (CBD), a constituent of
cannabis which is not psychoactive as is THC. The
manufacturer of Sativex, GW Pharmaceuticals, has
completed third stage clinical trials of Epidiolex,
which like Marinol and Sativex is a pharmaceuticalquality medication with standardised dosage,
strength and purity, but with high levels of CBD.
Epidiolex is available in the USA for trials, (Epilepsy,
Australia, 2014) and the Federal Government
announced in February 2016 that it will commence
trials of Epidiolex in Australia shortly (Beech,
2016). This scraps the NSW Government’s plans to
produce their own similar preparation in NSW.

“

a quasilegalisation
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cannabis via
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”

Media agenda? Most likely recreational use
So why was the media, along with the ACT and
Victorian Governments, continuing to call for medical
cannabis to be legalised when it was already legal?
The answer is very simple. In the USA, where
States hold referenda on various legislative issues
at the time of each federal election, the cannabis
legalisation lobby has had a fighting-fund spend that
is 25 times greater than the anti-cannabis lobby, as
disclosed in a November 2012 meeting I had with Gil
Kerlikowske, the US drug Czar at NSW’s Parliament
House. Some of the world’s richest men such as
George Soros, who spends up to half a billion dollars
yearly on his social liberalism agendas, heavily fund
these referenda on legalising cannabis, first for
medical purposes and then for outright recreational
use as has now happened in a number of US States.
The massive spend on repeated TV advertising
shows sick people claiming in-camera their dire
need to access medical marijuana. Despite many
of these televised conditions not being supported
by any objective evidence, more than 20 States
have voted to legalise medical marijuana, many with
home-grown cannabis legally available to patients.
Ruse of recreational use
What the US public is not told, nor has the
prevention lobby the money to tell them with any
penetration, is that 95% of medical marijuana
‘patients’ are previous recreational users. Surveys
by the US Institute of Medicine in the late 1990s had
found as much (Institute of Medicine, 1999). Nor
are they told that cannabis has only a handful of
conditions it alleviates, and almost all of these have
far more effective medications available. The public
is not told that cannabis actually causes the chronic
back pain which many claim cannabis alleviates,
quite clearly as part of its own withdrawal syndrome,

along with other conditions arising from its use which
cannabis will always appear to alleviate.
Effectively, US States have allowed popular
vote to determine what is a medicine based on
emotive advertising, rather than the normal scientific
regulatory processes applied to every other available
medicine. Predictably, there are tens of thousands in
each corresponding US State citing conditions they
claim cannabis alleviates, however, in the early years
of Nevada’s legislation, 93% of the maladies claimed
were severe pain (53%), muscle spasm (29%) and
severe nausea (11%) (Gogek, 2015) which cannot
be objectively verified by a doctor and must be
accepted on faith. The Australian Disability Support
Pension constantly faces many similar health claims
which are just as unverifiable, many of which are
exposed in the media as false.
Medical cannabis has, in many of those US
States which have poorly framed medical cannabis
laws, become the route to ‘legalised’ recreational
use (Gogek, 2015). Colorado introduced medical
cannabis laws in 2001, and by 2004 had just 512
patients accessing raw cannabis leaf, which is
available in that state for smoking or ingestion. By
2010 the number had exponentially grown to more
than 100,000 according to data from Colorado’s
Department of Public Health and environment, with
94% registered for the unverifiable condition, pain.
Oregon has 94% claiming pain while Arizona has
90%.
Pain profiles and pain management
There are well established profiles for patients of
chronic pain across all Western countries, where
patients are more predominantly women and those
aged 60 and above. For instance, a 2001 study by
Sydney University’s Pain Management Research
Centre (Blythe et al., cited in Access Economics,
2002) found 54% of patients were women (p. 15),
with men suffering in their sixties and women in
their eighties (p. 12). Yet the profile for pain patients
using medical cannabis in the USA is very different.
A 2007 study of 4,000 medical cannabis patients in
California (Gogek, 2015), found that their average
age was 32, 75% were male and 90% had started
using cannabis while teenagers, an identical age
and gender profile to that of recreational users
across the US. This discordant profile means that
medical cannabis in the various states of the US has
mainly amounted to a quasi-legalisation strategy
for recreational use of cannabis via subterfuge and
ruse.
Approving recreational use of a drug?
It is no surprise then that the full legalisation of
cannabis for recreational use has followed in six
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US States or jurisdictions since the introduction
of medical cannabis laws. Pot activists are now
agitating for legalisation of recreational use in
every State. Such legalisation is in open breach of
the United Nations’ Single Convention on Narcotic
Drugs which applies to every country world-wide, but
President Obama and Presidential hopeful, Hillary
Clinton, are too compromised to intervene federally
– the aforementioned George Soros is the largest
financial backer of the Democrats.
A contemporary Australian issue
In Australia, where no similar referendums are held,
the pathway to legalisation is not so easily bought.
Shaping opinion
In 2012, the Australia21 forum, (Douglas &
McDonald, 2012) with influential Australians such
as former NSW Premier Bob Carr and former NSW
Director of Public Prosecutions Nicholas Cowdery,
began agitating in the media for the legalisation of
all drugs – heroin, cocaine, speed, ice, ecstasy and
cannabis – with the televised media giving them
plenty of airplay, albeit fairly with Drug Free Australia
brought in to debate the issue on air. By contrast
the Sydney Morning Herald held a public debate
at Sydney University where five drug legalisation
advocates were pitted against a single prevention
advocate. Not one contrary opinion was reproduced
in any print media Australia-wide, including in
Murdoch papers such as The Australian or the Daily
Telegraph, which usually represent the conservative
voice within Australia.
By 2013, with that push gaining no traction with
the public, Australia21 operatives looked for a new
pathway to legalising drugs, and found it in a young
NSW cancer patient from Tamworth, Dan Haslam
(Knott, 2014), who publicised his need to smoke
cannabis to alleviate chemotherapy-induced nausea.
And it is precisely this that the media is fighting
for—not for medical cannabis per se, which is clearly
already legal, but for crude non-pharmaceutical
cannabis products which they hope will not be
regulated by the TGA, all for the end-game, it would
seem, of getting home-grown cannabis made
available to all as it is in many US States.
Government initiatives - legislative action
In the ACT in late 2014, the Greens Bill (ACT
Government, 2014) to legalise medical cannabis
specifically stated that Sativex was not part of
their plan, despite Sativex delivering all the same
cannabinoids via a safer and faster-acting delivery
system than hash cookies, bongs or crude cannabis
oils. Their Bill sought to legalise home-grown
cannabis, with up to nine cannabis plants being

considered a non-trafficable quantity. What they
failed to tell the public was that a single cannabis
plant can produce 5 crops a year with a total 2,500
grams, enough to make 8,600 joints (Drug Free
Australia, 2015). With the average medical cannabis
patient in the US requiring 1.5 grams per day or 550
grams per year, a single plant provides five times the
needed quantity, which in the US has provided too
much temptation for patients who could use extra
cash. Nine cannabis plants, as proposed by the
Greens Bill, could have produced a street value of
$270,000 worth of cannabis per year per individual
– a nice little earner. The Bill was defeated (McElroy,
2015), a victory for common sense.
The current position
In February 2016 Federal Health Minister Sussan
Ley announced legislation (Beech, 2016) allowing
cannabis to be grown in Australia for medical use
under strict cultivation conditions similar to the opium
poppy crop in Tasmania (Yaxley, 2015). A centralised
regulator controlled by the strictures of the Australian
TGA would oversee the entire production of
medical cannabis products which would be only
pharmaceutical products. No raw cannabis products
would be available for smoking or ingestion. This
undermines the pathway to legalising recreational
use. As it is, the legislation is a concession to pot
activists in that it is only pegged to TGA strictures,
not directly under the control of the TGA, which will
more easily allow political tampering in the future.

“

Costings and consequences
In late 2015 Ley had suggested much lower costs of
producing cannabis oils under this regulator, claiming
that Australia might produce medical cannabis
pharmaceuticals cheaper than those already available
from overseas. She particularly mentioned that they
could be made available in the form of tinctures or
oils. What Ley may not have realised is that homemade cannabis oils can attain THC concentrations of
80% (High Times, 2014) as compared to 3% in bushgrown smoked cannabis. This could promote extreme
cannabis intoxication. It was surmised that Australian
pot activists may be seeing oils as their product of
choice for use in e-cigarettes (Greig, 2013) where
tobacco or cannabis oil is vaporised and publicly
‘smoked’ with no odour to allow detection by police.
Drug Free Australia called for legislative measures to
close down this pathway to recreational use via the
medical cannabis ticket and pain alibi.
It is doubtful that Australia can reduce the cost of
pharmaceutical cannabis medications substantially.
As it is, the cost to medical cannabis users of illegal
cannabis purchased on a street corner, at an average
$12.00 a gram or $500 per month, is exactly the same
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cost as cannabis bought from commercial growers
by patients in the USA, as verified in a submission
by cannabis legalisation organisation NORML (2009)
to an Obama Inquiry. The UK-produced Sativex also
costs patients $500 per month (NSW Legislative
Council, 2013). Oddly enough, NSW Premier
Baird’s plan to produce cheaper pharmaceutical
cannabinoids led to advertising for local expertise
to develop a CBD-rich medication for children with
epilepsy-like seizures, as disclosed in a January
2015 Drug Free Australia meeting with NSW Health
Minister. It resulted in the Government announcing
trials with Epidiolex purchased from the UK (News
Limited, 2015).

“
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Visioning our future
Present indications are that the Federal legislation
will avoid many of the problems besetting the US
legislations. There is a high price to be paid for having
lax medical marijuana laws – the deleterious effect
it has particularly on the young people for whom
cannabis, as with alcohol, could never be legalised.
In Colorado, which has allowed six plants per patient
since 2009, 74% of teenagers surveyed entering
rehabilitation for cannabis addiction reported that they
sourced cannabis from medical marijuana patients
(Salomonsen-Sautel, Sakai, Thurstone, Corley, &
Hopfer, 2012). This issue of diversion of cannabis
to minors for recreational use has been the most
dangerous aspect of the push for crude cannabis,
considering the damage done to any teenager’s
developing brain. A recent Lancet study (Di Forti et
al., 2015) found that daily users of strong forms of
cannabis have a five times greater risk of developing
psychoses, many of which will debilitate them for life.
Public opinion on drug use
Australians do not want drug use entrenched in this
country for 98% of the 24,000 people surveyed in the
2013 National Drug Strategy Household Survey did
not approve the use of heroin, ecstasy, speed, ice
and cocaine, 90% did not approve the regular use
of cannabis, and 74% of Australians did not want to
legalise cannabis. Further, 93% or more, depending
on which drug is considered, did not want to legalise
the other illicits. But persistently, a group working
since 1992 has sought to change Australia’s drug
laws, seeing the choice to use any drug as a human
right. It is a ‘right’ that doesn’t exist because there is
worldwide agreement that the harms presented by
illegal drugs are unacceptable. That hasn’t stopped
the drug law reformers.
Challenging legalisation advocacy
The chosen pathway to a final goal of drug
legalisation has been via harm reduction

interventions, which presuppose an acceptance of
illicit drug use with free needle programs, methadone
maintenance and injecting rooms. The President
of the Australian Drug Law Reform Foundation—
Australia’s drug legalisation movement—is also
lauded as the father of harm reduction in Australia
(Wodak, 2012), having formally set up the first
needle exchange as an act of civil disobedience
in the mid 1980s. In a speech reproduced in the
Australian Drug Law Reform Foundation newsletter
he (Wodak, 2005, para. 1.) stated that, “it is time
to move from the first phase of harm reduction –
focusing on removing adverse consequences – to
a second phase which concentrates on reforming
an ineffective and harm generating system of global
drug prohibition.” As a leading member of the
Australia21 group, and the most vocal advocate for
Dan Haslam’s right to smoke cannabis as a cancer
sufferer, his stated aims give a clear picture of what
was behind the push for non-pharmaceutical forms
of medical cannabis. For them, the acceptance
of medical cannabis will ultimately lead to an
acceptance of recreational use.
In 2012 almost all Australian media outlets gave
Australia21 a platform to declare that the ‘war on
drugs’ had failed and it was time to scrap prohibition.
At that time, prevention organisations responded by
asking, “What war on drugs?” (Channel 7 Sunday
Sunrise, 2012). When Australia has done everything
to pander to drug users by handing them free
needles, maintaining drug users on methadone for
up to 40 years, and giving them injecting rooms, this
cannot be construed as a war on drugs. For 28 years
now we have been facilitating drug use, anything
but a war. And if we want to call the regular policing
of drug use a ‘war on drugs’ why think it has failed?
We don’t abandon our ‘war’ on stealing, speeding
or rape because we know we can never eradicate
them, but we always seek to control them because if
we don’t the societal harms are catastrophic.
Maintain the ‘war’
In 1998 the Howard government implemented the
Tough on Drugs strategy, which maintained the
harm reduction strategies that continue to facilitate
drug use, but introduced a new and stronger
prevention emphasis. Between 1998 and 2007
heroin use reduced by 75%, speed and ice use
by 40% and cannabis use by 50%. While cocaine
use rose by 15% and ecstasy use by a worrying
46%, assessment suggests successes outweighed
failures (Australian Institute of Health and Welfare,
2011).
A comparison of the legal drugs, alcohol and
tobacco, with the illegal drugs shows the success of
prohibition. Alcohol is used by 81% of Australians,

14 | TEACH | v10 n1

TEACHjournal 10-1.indd 14

28/06/2016 9:50 am

Teaching & Professional Practice

while tobacco in its heyday was used by 65% of
Australians. It has taken many years and millions
of dollars to reduce tobacco use in Australia.
By comparison the illicits are a fraction of those
percentages - opiates are used by 0.5%, cocaine
by 2%, amphetamines by 2%, ecstasy by 2.5% and
cannabis by 10%.
It is clear that Australians want less drug use, not
more. Legalisation of drugs will only add significant
use. Medical cannabis as the media was promoting
it, would definitely have added more. Australia is
taking a path which has learned from the mistakes
of the USA, a path which is compassionate but
sensible.
Educators are encouraged to lead their students
in discussions considering the social influences
affecting wellbeing, as required by the PDHPE
curriculum of NSW or its equivalent in other states,
but in particular to address the impact of pressure
groups influencing legislative processes providing
for, and protecting health. The current promotion of
a medical use of marijuana provides a useful case
study within which the complexity of community
interaction becomes apparent. It highlights both the
importance and difficulty of maintaining an open,
clearly informed, research based decision-making
political process. TEACH
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